A new study from researchers at Boston-based Harvard Medical School found the spike protein of the SARS-CoV-2 virus may linger in long COVID-19 patients’ blood for up to a year after infection. The findings reinforce a leading theory among scientists that lingering virus particles stimulate an immune system reaction that causes symptoms.
